First Patient Treated in US Study of Moximed Atlas System for Uni Knee OA

The first patient has been treated in an FDA-approved Investigational Device Exemption study for Moximed's Atlas® unicompartmental unloading implant.

Atlas represents the latest iteration of technology employed in the KineSpring system for the treatment of medial knee osteoarthritis, providing the same 30 lbs. of joint unloading in a...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us